Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Linguistic Validation of the "German Lung Fibrosis Health Related Quality of Life Questionnaire"].

Pneumologie (Stuttgart, Germany)·2021
Same author

Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).

Zeitschrift fur Rheumatologie·2020
Same author

[DGP Interstitial Lung Disease Patient Questionnaire].

Pneumologie (Stuttgart, Germany)·2018
Same author

[Rudolf Virchow (1821-1902) and the Origin of the Term "Granuloma"].

Pneumologie (Stuttgart, Germany)·2016
Same author

[Marcello Malpighi (1628-1694) and the Terms Miliary and Tubercle].

Pneumologie (Stuttgart, Germany)·2016
Same author

Diagnostic Gain from Surgical Biopsy for Interstitial Lung Disease - When is it Worth the Risk?

Pneumologie (Stuttgart, Germany)·2016

Related Experiment Video

Updated: Jun 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Non-specific interstitial pneumonia (NSIP)].

H-P Hauber1, I Bittmann, D Kirsten

  • 1Medizinische Klinik, Forschungszentrum Borstel, Borstel, Germany. hphauber@fz-borstel.de

Pneumologie (Stuttgart, Germany)
|March 26, 2011
PubMed
Summary
This summary is machine-generated.

Non-specific interstitial pneumonia (NSIP) is a type of interstitial lung disease that can occur alone or with other conditions like connective tissue disease. This review covers NSIP's causes, symptoms, diagnosis, and treatment.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Related Experiment Videos

Last Updated: Jun 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Area of Science:

  • Pulmonology
  • Rheumatology
  • Pathology

Context:

  • Non-specific interstitial pneumonia (NSIP) is classified under idiopathic interstitial pneumonias (IIP).
  • NSIP is frequently observed as an interstitial lung disease manifestation in patients with connective tissue diseases.
  • Understanding NSIP's diverse associations is crucial for accurate diagnosis and management.

Purpose:

  • To provide a comprehensive overview of Non-specific interstitial pneumonia (NSIP).
  • To detail the definition, classification, etiology, pathogenesis, histology, clinical presentation, diagnostic markers, and therapeutic strategies for NSIP.
  • To differentiate idiopathic NSIP from secondary NSIP patterns.

Summary:

  • This review synthesizes current knowledge on NSIP, encompassing its pathological features, clinical characteristics, and diagnostic modalities.
  • It examines the role of serological markers, lung function tests, and radiographic findings in identifying NSIP.
  • The etiology, pathogenesis, treatment options, and prognosis associated with NSIP are thoroughly discussed, with a focus on idiopathic NSIP.

Impact:

  • Enhances understanding of NSIP in both idiopathic and secondary forms.
  • Provides a valuable resource for clinicians and researchers managing interstitial lung diseases.
  • Aids in differentiating NSIP from other interstitial lung diseases, improving patient outcomes.